Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study - van der Zee, H H; Laman, J D; de Ruiter, L (Br J Dermatol, 2012)
et al.